CN
368-53-6
应用筛选条件
关键词:'368-53-6'
显示 1-30 共 93 条结果 关于 "368-53-6" 范围 技术文档
Monoclonal Anti-Casein Kinase 2a Clone 1AD9 produced in mouse purified immunoglobulin
et al., Biochem. J., 232, 767-771
(1985).
9. Meggio, F., and Pinna, L.A., FASEB J ., 17, 349-368
(2003).
10. Unger, G.M., et al., Curr. Cancer Drug Targets, 4,
77-84 (2004).
Product Information Sheet - A3306
Valentin-Gamazo, C., Food Chem.,
81(4), 511-515 (2003).
9. Kim, S.-K. et al., Starch, 55(8), 366-368 (2003).
10. Ruiz-Ruiz, J. et al., Food Sci. Technol., 41(10),
1799-1807 (2008).
11. Polat
XP725 Antibody Number-Lot Number 071M4826
4 25 26 27 28 49 50 51 52 73 74 75 76
1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79 80
1.3 9 10 11 12 33 34 35 36 57 58 59
Product Information Sheet - P6024
pp. 235,349.
11. ibid., (1983). pp. 6, 80, 147, 345.
12. ibid., (1983). pp. 134, 216, 224, 230,
234.
13. ibid., (1983). pp. 330, 335, 340, 352,
368, 435.
14. ibid., (1983).
p53 And Related Products
PS
20 mg
100 mg
Anti-p53 (Ab-6) (Pantropic)
Mouse mAb (DO-1)
OP43 Liquid, purified . Immunogen used was recombinant human wild type p53 . Recognizes the ~53 kDa wild-
type and mutant p53 protein
Data Sheet - P8125
, D.,
Enzyme Handbook 7, EC 1.11.1.7, 1-6 (1993).
48. Zollner, H., Handbook of Enzyme Inhibitors,
2nd ed., Part A. VCH Verlagsgesellschaft,
pp. 367-368 (1993).
Notice
We provide information
User Guide-MBD6000
The human tumor microbiome is composed of tumor type-specific intracellular bacteria.
Science. 368:973-980 (2020).
Notice
We provide information and advice to our customers on application technologies
Product Information Sheet - SH0811
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH0111
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2311
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2111
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH0411
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH1111
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH0711
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2911
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH3011
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH1911
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH1811
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH0511
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH1311
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2411
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2211
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH0211
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2811
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2711
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2511
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH2611
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
Product Information Sheet - SH1011
Apoptosis Pathway 443 3512 7.9
SH2911 B-Cell Activation 99 661 6.7
SH2211 Cell Adhesion Genes 368 2396 6.5
SH0811 Cytokine and Chemokine 106 538 5.1
SH1311 Cytokine and
BRAND Katalog EN
0.10 14/23 368 49
200 0.15 14/23 368 50
250 0.15 14/23 368 51
500 0.25 19/26 368 52
1000 0.4 24/29 368 53
2000 0.6 29/32 368 54
W = Wide neck
An Update on Ligands for Prostanoid Receptors
Pharmacol. Exp. Ther., 275, 368-373 (1995).
51. Yokotani, K., et al., Eur. J. Pharmacol., 459, 187-193 (2003).
52. Kiriyama, M., et al., Br. J. Pharmacol., 122, 217-224 (1997).
53. Bygdeman, M., Danielsson
1/4